Evidence map›Paper›PMID 14742909›Full record

ReviewJournal of molecular neuroscience : MN2004

Is there structural specificity in the reversible protein aggregates that are stored in secretory granules?

Camille Keeler, Michael E Hodsdon, Priscilla S Dannies

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular neuroscience : MN, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Camille KeelerDepartment of Pharmacology and Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Michael E Hodsdon
Priscilla S Dannies
Yale University · US

Funding

STRUCTURAL BASIS OF CHEMOKINE RECEPTOR RECOGNITIONK08AI001806 · NIAID · YALE UNIVERSITY · PI HODSDON, MICHAEL E · 2000 to 2003
$503k
REGULATION OF PROLACTIN STORAGER01DK046807 · NIDDK · YALE UNIVERSITY · PI DANNIES, PRISCILLA S · 1993 to 2001
$476k
NIAID NIH HHS AI01806NIDDK NIH HHS DK46807
6 · The paper itself

Abstract

There are several steps that must occur for secretory granules to form: (1) Secretory proteins that make up the dense cores of the granules must be concentrated; (2) membrane proteins necessary for granule function must accumulate in the correct location; and (3) inappropriate membrane proteins and excess membrane must be removed. Reversible aggregation of secretory granule proteins provides a mechanism for concentrating and sorting these proteins. There is specificity in the way secretory granule proteins are treated in cells that make granules. The specificity has been shown in some cases to occur after the aggregation process, so that granules containing different aggregates function differently. An explanation could be that a property of the aggregate, such as a surface motif, might influence the accumulation of membrane proteins necessary for granule function. Such a conclusion implies that the aggregates are not amorphous but have structure. Use of NMR spectroscopy to investigate changes in the environment of amino acid residues in secretory granule proteins as they form oligomers by using 15N relaxation times might provide a means to determine which residues are specifically involved in aggregation.

Indexed as

Amino Acid MotifsAmino Acid SequenceAnimalsBodily SecretionsHumansIntracellular MembranesMacromolecular SubstancesNuclear Magnetic Resonance, BiomolecularProlactinProteinsSecretory VesiclesMacromolecular SubstancesProlactinProteins

Identifiers

PMID14742909
OpenAlexW1967709810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.